Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FSMA deadlines, adulteration bill, pharma supply chain pilot

This article was originally published in The Tan Sheet

Executive Summary

FSMA deadlines set in consent decree; supplement adulteration legislation introduced; Maximus Niterider has GMP problems; modified risk claim on tobacco committee agenda; and more In Brief.

You may also be interested in...



Judge Orders FDA, Food Safety Group To Set FSMA Implementation Date

FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.

QUOTED. 27 October 2020. Michael Mussallem.

TAVR procedure volumes have returned to or exceeded pre-pandemic levels in most locations, Edwards LifeSciences CEO Michael Mussallem said during the company’s 21 October earnings call.

US Rep. Pallone Demands Answers From FDA On Seeming Hair-Smoothing Formaldehyde Ban ‘Reversal’

Internal FDA emails obtained by the Environmental Working Group through a FOIA request indicate that the agency was moving toward rulemaking in 2016 to restrict or prohibit use of formaldehyde in heated hair-straightening cosmetics, but seemingly abandoned the initiative. That has Congress, NGOs and other stakeholders asking questions and renewing calls for cosmetics regulatory reform.

Topics

Related Companies

UsernamePublicRestriction

Register

OM000882

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel